Cancer-Related Lymphedema: Clinical and Epidemiological Features in Mexico

Luis López-Montoya *

Fi Fisitoerapia Integral S. C. Research Group, Calle San Juan Bosco 1332, 45040, Zapopan, Jalisco, Mexico.

Yucari L. Cabanillas

Fi Fisitoerapia Integral S. C. Research Group, Calle San Juan Bosco 1332, 45040, Zapopan, Jalisco, Mexico.

Joceline S. Aguirre

Fi Fisitoerapia Integral S. C. Research Group, Calle San Juan Bosco 1332, 45040, Zapopan, Jalisco, Mexico.

K. Gabriela Saenz-Ramirez

Fi Fisitoerapia Integral S. C. Research Group, Calle San Juan Bosco 1332, 45040, Zapopan, Jalisco, Mexico and Universidad Marista Valladolid, José Juan Tablada 1111, Santa Maria de Guido C.P. 58090, Morelia, Mich, Mexico.

Maria T. Zarate-Sánchez

Fi Fisitoerapia Integral S. C. Research Group, Calle San Juan Bosco 1332, 45040, Zapopan, Jalisco, Mexico and Universidad Marista Valladolid, José Juan Tablada 1111, Santa Maria de Guido C.P. 58090, Morelia, Mich, Mexico.

Angel D. Lopez

Fi Fisitoerapia Integral S. C. Research Group, Calle San Juan Bosco 1332, 45040, Zapopan, Jalisco, Mexico.

*Author to whom correspondence should be addressed.


Abstract

Backgroundː There is a lack of clinical and epidemiological knowledge about cancer-related lymphedema in Mexico. The objective of this study is to present a broad and deep report of cancer-related lymphedema’s clinical characteristics and epidemiological features based on the analysis of CRL patients’ data, collected from a specialized rehabilitation clinic in Mexico.

Methodsː This is a cohort study based on the analysis of clinical data gathered between 2015 and 2022. The study was developed in a private clinic that specializes in oncological patients’ rehabilitation. Clinical assessments and interviews were performed to collect each case’s clinical history, considering diverse clinical characteristics and demographic information, classified in a matrix, and statistically evaluated.

Resultsː Among 307 lymphedema patients, gender distribution was represented by 87.9% (270) female and 12.1% (37) male; mean age of 54.5 years (± 32.5); 79.8% of the patients corresponded to breast cancer diagnosis, the rest of them were associated with other 19 different types of cancer. 90.2% of patients underwent some lymph node removal procedure, 68.1% of patients received fractioned radiotherapy sessions, and 87.7% received some chemotherapy scheme treatment. 64% of patients had a diagnosis of lymphedema and had onset symptoms of lymphedema in the first 5 years after oncological interventions and/or cancer diagnosis, most of them during the first 2 years. The general distribution of clinical staging was: 23.7% in stage 0; 20.1% in stage I; 44.6% in stage II, and in stage III 11.4%. Regarding body mass index, it was found a mean of 26.7 BMI. 61.2% of patients ranged between overweight and obesity. 43.3% of patients with CRL reported a disability to perform one or more activities due to lymphedema. 80% of patients had no physical activity or performed under the minimal physical activity recommended for the population group they belong.

Conclusionː This study reports broad epidemiological and clinical features of a group of cancer-related lymphedema patients in Mexico, it was possible to identify diverse potential factors and relations that influence the clinical features of CRL; it is necessary to explore all factors and the interactions among them for a better understanding of CRL patients in the country.

Keywords: lymphedema, secondary lymphedema, cancer-related lymphedema, lymphedema in Mexico


How to Cite

López-Montoya, Luis, Yucari L. Cabanillas, Joceline S. Aguirre, K. Gabriela Saenz-Ramirez, Zarate-Sánchez Maria T., and Angel D. Lopez. 2022. “Cancer-Related Lymphedema: Clinical and Epidemiological Features in Mexico”. Cardiology and Angiology: An International Journal 11 (4):152-61. https://doi.org/10.9734/ca/2022/v11i430218.

Downloads

Download data is not yet available.